Latest News and Press Releases

REYKJAVIK, ICELAND (July 29, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for...

Reykjavík (29. júlí 2026) — Alvotech tilkynnti í dag að Matvæla- og lyfjaeftirlit Bandaríkjanna (FDA) hefði lokið úttekt á framleiðsluaðstöðu félagsins í Reykjavík sem fram fór í maí sl. FDA gerir...

REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar...

Í viðhengi er tvær tilkynningar sem lagðar voru inn til birtingar hjá fjármálaeftirliti Lúxemborgar, Luxembourg Commission de Surveillance du Secteur Financier (CSSF) varðandi viðskipti stjórnenda og...

Attached are copies of two filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the pledging...

$75 million additional term loan facility maturing December 31, 2027, led by GoldenTree Asset ManagementFollows recent $165m equity raise strengthening cash positionIncluding equity financing and...

— $75 million additional term loan facility maturing December 31, 2027, led by GoldenTree Asset Management — Follows recent $165m equity raise strengthening cash position — Including equity...

- Hópur fjárfesta undir forystu GoldenTree Asset Management veitir Alvotech viðbótarlán að fjárhæð 75 milljónir dala - Lánveiting kemur í kjölfar nýlegrar hlutafjáraukningar að andvirði 165 milljóna...

Í viðhengi er tilkynning sem lögð var inn til birtingar hjá fjármálaeftirliti Lúxemborgar, Luxembourg Commission de Surveillance du Secteur Financier (CSSF) varðandi viðskipti stjórnenda og tengdra...

Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition...